Penlon has received Medical Device Marketing Authorisation (MDMA) to market the Prima Anaesthesia Machine Range in Saudi Arabia, and has successfully registered the Prima 450 and Prima 460 Anaesthesia Machines for sale in China.
Penlon has received Medical Device Marketing Authorisation (MDMA) to market the Prima Anaesthesia Machine Range, including the Prima 465, Prima 451 MRI and Prima 320, in the kingdom of Saudi Arabia. The licence also includes the AV-S MRI Anaesthesia Ventilator and the Sigma EVA Desflurane Vaporizer.
The licence was issued by the Kingdom of Saudi Arabia Food and Drug Authority in June and is the culmination of collaborative effort between the team at Penlon and our Saudi Arabia distributor.
Penlon has successfully registered the Prima 450 and Prima 460 Anaesthesia Machines for sale in China. The Penlon Sigma Delta Anaesthesia Vaporizer is also registered as a Penlon product in China.
The licences were issued by the Chinese Food and Drug Administration in June and are the culmination of a collaborative effort between the teams at Penlon global headquarters and Penlon’s regional office in China.
17/09/2026
Penlon will exhibit at The Difficult Airway Society (DAS) Annual Scientific Meeting 2026 in November.
08/09/2026
Medcaptain Medical Technology Co., Ltd. was listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited on 7 September 2026.
27/08/2026
Penlon launches the Supaera 50 and Supaera 50 Pro, the company’s next-generation Anaesthesia Delivery Systems.
26/08/2026
Penlon will be exhibiting a range of anaesthetic machines, patient monitors, and accessories at the Association of Anaesthetists Annual Congress 2026 in September.